Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.14

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $10.44 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• IMF chief says global economy weathered Iran war shock well
• BofA Securities on Kanzhun Ltd. (BZ): 'We watch for Co.’s execution pace of the price hike strategy'
• Sonoco to raise EMEA paperboard prices by €60 per ton